8 May 2024 in Psychiatry Research
25 November 2024 in Journal of Alzheimer’s Disease
Background: Persons with Alzheimer's disease (AD) present with changes in mood, sleep, and arousal that may precede the clinical manifestation of cognitive decline. These early symptoms can be driven by changes in the serotonergic (5-HT) nuclei of the brainstem, particularly the dorsal raphe nucleus (DRN). It is unclear why all 5-HT neurons do not simultaneously develop AD pathology that progresses at the same rate. Objective: We sought to identify any underlying genetic components associated with susceptibility or resistance of 5-HT neurons to AD pathology. Methods: The Visium Spatial Gene Expression platform was used to identify transcriptomic changes across the DRN in a preclinical model of early AD, human tau-overexpressing mice (htau mice). We further used RNAscope and immunohistochemical assessment to validate findings of primary interest. Results: We find that the DRN of htau mice differentially expresses AD-related genes, including those related to kinase binding, ion channel activity, ligand-receptor interactions, and regulation of serine/threonine kinases. We further find that computational sub-clustering of the DRN is consistent with previous circuitry-driven characterizations, allowing for spatial bounding of distinct subregions within the DRN. Of these, we find the dorsolateral DRN is preferentially impacted by 5-HT neuron loss and development of tau pathology, which coincides with increased expression of the long noncoding RNA Map2k3os . Conclusions: Map2k3os may serve regulatory roles relevant for tau phosphorylation and warrants further investigation to characterize its interactions. Overall, this report demonstrates the power of large-scale spatial transcriptomics technologies, while underscoring the need for convergent-data validation to overcome their limitations.
11 September 2025 in Alcohol
JAJessica Marie Hunter Alberhasky
Jessica Marie Hunter Alberhasky
CMCatherine Anne Marcinkiewcz
Catherine Anne Marcinkiewcz
+1
19 September 2025 in Journal of Cell Science
The olfactory bulb (OB) contains multiple, parallel projection neurons to relay the nature of a stimulus. In a mouse ex vivo slice preparation, we used patch-clamp electrophysiology to measure intrinsic properties, excitability, action potential (AP) shape, voltage-activated conductances, and neuromodulation in the newly-categorized superficial tufted cells (sTCs) compared with those of mitral cells (MCs). We propose that a marked difference in voltage-dependent current represents distinct ion channel populations that affect the kinetics of action potentials, and evokes an increase in sTC firing frequency, albeit both types of projection neurons having similar AP spiking activity. Triple-colored immunofluorescence and RNA scope were used to detect co-localization of the Kv1.3 ion channel and the insulin receptor in sTCs, with ∼73% of sTCs expressing both. The sTCs were modulated by bath application of insulin – increasing AP firing frequency by 97%, attributable to an 8% decrease in the intraburst interval, and a reduction of the latency to first spike by 37%. We conclude that there may be a range of neuromodulators of sTCs that may alter excitability and fine-tune olfactory information processing or metabolic balance.
12 May 2026 in Alzheimer's & Dementia
NBNagalakshmi Balasubramanian
Nagalakshmi Balasubramanian
JAJessica Marie Hunter Alberhasky
Jessica Marie Hunter Alberhasky
+3
INTRODUCTION: Our previous studies demonstrate that htau mice recapitulate many of the neuropsychiatric features of early Alzheimer's disease (AD), and that the dorsal raphe nucleus (DRN) contains distinct subregions. Herein, we investigate the vulnerability of the centromedial DRN to pathologically phosphorylated tau (p‐tau), a region composed predominantly of dually serotonergic/glutamatergic (5HT/glut) neurons. METHODS: We use a battery of computational, molecular, biophysical, and behavioral techniques to assess molecular changes in the centromedial DRN across preclinical and post mortem settings. RESULTS: The centromedial DRN contains 5HT/glut neurons that differentially express ion‐channel genes in the htau mouse. This is associated with increased neuronal excitability, which may promote p‐tau accumulation. At Braak II, KCNA4 is reduced in 5HT/glut neurons in AD, which are especially vulnerable to p‐tau compared to 5HT‐nonglut neurons. DISCUSSION: Tau‐mediated dysfunction of the DRN may be driven by changes in ion channel activity that concomitantly promote the spread of p‐tau in Braak progression.
17 October 2025 in bioRxiv
JAJessica Marie Hunter Alberhasky
Jessica Marie Hunter Alberhasky
+3
INTRODUCTION: We previously demonstrated that htau mice recapitulate many neuropsychiatric features of early Alzheimer’s disease (AD), and that the dorsal raphe nucleus (DRN) contains distinct subregions. Herein, we investigate vulnerability of the centromedial DRN to pathologically-phosphorylated tau (pTau), a region composed predominantly of dually serotonergic/glutamatergic (5HT/glut) neurons. METHODS: We use computational, molecular, biophysical, and behavioral techniques to assess the centromedial DRN across preclinical and post-mortem settings. RESULTS: The centromedial DRN contains 5HT/glut neurons that differentially express ion-channel genes in the htau mouse. 5HT/glut neurons exhibit increased excitability, which we demonstrate may dually promote pTau accumulation and the severity of depressive-like behaviors in htau mice. At Braak 2, KCNA4 is reduced in 5HT/glut neurons in AD, which are especially vulnerable to pTau compared to 5HT-nonglut neurons. DISCUSSION: Tau-mediated dysfunction of the DRN may be driven by changes in ion channel activity that concomitantly promote the spread of pTau in Braak progression.